ArticleCancer cell2021
I-SPY2 platform: New lessons from the olaparib and durvalumab combination in breast cancer treatment.
Jose Perez-Garcia et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleCancer cell2021
Jose Perez-Garcia et al.PubMed ↗Publisher ↗
No numbers read from the abstract.